Passionate about #CellTherapy #GeneTherapy #womeninstem Tweets are my opinion. Retweets are not endorsement #WeAreCytiva and #getvaxxed #getboosted
Sydney, New South Wales
Joined May 2009
- Tweets6.2K
- Following1.2K
- Followers1.2K
- Likes8.8K
Join n-Lorem Foundation's 2024 Nano-Rare Patient Colloquium. This year’s colloquium will bring together patients, physicians, and supporters to create a cohesive, empathetic, and knowledgeable nano-rare community.
This event is open to all—register now! linkedin.com/posts/nlorem_nr…
A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that envelop genetic material of adeno-associated viruses (AAV), to improve gene therapies for muscle diseases. medicalxpress.com/news/2024-…
BioMolecular Horizons is in Melbourne this coming week26th IUBMB
17th FAOBMB
22nd ComBio
Swing by Cytiva's booth to explore breakthrough solutions and chat with our specialists to shape the future of research together.
cytiva.link/h518x
Great commentary on the topic of in vivo CAR T therapy>
Drug developers want to reprogram immune cells directly in the body, opening up new gene therapy frontiers in cancer and autoimmunity. nature.com/articles/d41573-0…
Cytiva is aware that tackling scope 3 emissions can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review: cytiva.link/j1es6.
Enter for the opportunity to have your cell image on the cover of @cytotherapy
Thanks @ISCTglobal
Mark your calendars and start collecting the best images from your lab. Get your cells ready, get creative, capture the beauty of your lab work and share it with the world!
Content opens on August 19, 2024.
Learn more: buff.ly/4cnsCvd
Janet Macpherson (she/her) retweeted
The Guidelines for minimal information on cellular senescence experimentation #MICSE are now available @CellCellPress: "...an overview of senescence markers in rodent tissues, transgenic models, non-mammalian systems, human tissues, and tumors and their use in the identification and specification of senescent cells."
Thanks to the leadership of Mikolaj Ogrodnik, Johannes Grillari, Marco Demaria @marc_dema @LBG_SHoW and arising in part from a productive Wiggers-Bernard conference authors.elsevier.com/sd/arti…
Janet Macpherson (she/her) retweeted
The ISCT Early Stage Professionals Committee is looking for dedicated and enthusiastic new members to support current and upcoming programs.
Join our CGT community today to foster global connections and progress your career.
Learn more: buff.ly/3SK1uQ7
Janet Macpherson (she/her) retweeted
Loved the ISCT ANZ poster session! Great opportunity for discussion, networking, and talking about research. So impressed by all the amazing work happening in our region! @ISCTglobal @ISCT_ESP #isctanz2024 #cellandgenetherapy @EmilyBlyth5 @jmacpher @eom_jennifer @bio_ora
Janet Macpherson (she/her) retweeted
#ISCTANZ2024 even more spectacular today as the main meeting gets underway.
In the joint @ISCTglobal AND @theASSCR joint session.
Here @jmacpher presents data on non-viral lipid nano particles for gene editing of CD34 stem cells.
See you next week in Queenstown NZ for #ISCTANZ2024 linkedin.com/posts/janet-mac…
We've been busy eliminating polystyrene in packaging.
Our new packaging has liners made with renewable paper and corn starch as their primary ingredients.
Did you miss the future of oligo synthesis? Don't worry, you can now access it on-demand webinar.
Watch now and learn how a unicorn's magic powers can bring you up to speed as quickly as possible: event.webcasts.com/starthere…
Thinking about bringing your oligo process in-house? It's a brave decision. Find out if it is for you
Explore what it entails and the benefits of owning your process in our on-demand webinar.
event.webcasts.com/starthere…
Calling all ÄKTA oligosynt users! Boost your yields in oligo synthesis in less than 30 minutes with our on-demand webinar. : event.webcasts.com/starthere…
Janet Macpherson (she/her) retweeted
📢 The application #deadline has been extended to 2 July 2024 – apply now!
🏃♂️Last chance to join this year’s edition.
🔗 esact.org/gene-cell-therapy-…
Janet Macpherson (she/her) retweeted
Participate in our survey to shape future technologist training programs in the field of Cell and Gene Therapy (CGT) and Advanced Therapies Medicinal Products (ATMP).
Access the survey now: buff.ly/3z9By9S
There is still time to submit an abstract for @Neo_CellTherapy 2024.
The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽
Thank you to all the stellar speakers and chairpersons.
Abstract deadline 10th June.
More info and registration: nct2024.eventbrite.com/
Janet Macpherson (she/her) retweeted
The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽
Thank you to all the stellar speakers and chairpersons.
Abstract deadline 10th June.
More info and registration: nct2024.eventbrite.com/